Revisiting inconsistency in large pharmacogenomic studies [version 3; referees: 2 approved, 1 approved with reservations]

In 2013, we published a comparative analysis of mutation and gene expression profiles and drug sensitivity measurements for 15 drugs characterized in the 471 cancer cell lines screened in the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE). While we found good...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhaleh Safikhani, Petr Smirnov, Mark Freeman, Nehme El-Hachem, Adrian She, Quevedo Rene, Anna Goldenberg, Nicolai J. Birkbak, Christos Hatzis, Leming Shi, Andrew H. Beck, Hugo J.W.L. Aerts, John Quackenbush, Benjamin Haibe-Kains
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	F1000 Research Ltd 2017-08-01
Serie:	F1000Research
Soggetti:	Cancer Therapeutics Drug Discovery & Design Methods for Diagnostic & Therapeutic Studies Pharmacogenomics
Accesso online:	https://f1000research.com/articles/5-2333/v3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!